{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:42:06Z","timestamp":1792402926465,"version":"4.4.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006593","name":"Board of Research in Nuclear Sciences","doi-asserted-by":"publisher","award":["35\/14\/07\/2017-BRNS"],"award-info":[{"award-number":["35\/14\/07\/2017-BRNS"]}],"id":[{"id":"10.13039\/501100006593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/565\/NE\/U-Excel\/2016"],"award-info":[{"award-number":["BT\/565\/NE\/U-Excel\/2016"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biophys Rev"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12551-020-00752-y","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T15:04:02Z","timestamp":1600182242000},"page":"1175-1186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Invasive and non-invasive therapies for Alzheimer\u2019s disease and other amyloidosis"],"prefix":"10.1007","volume":"12","author":[{"given":"Gaurav","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8048-3211","authenticated-orcid":false,"given":"Vibin","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"752_CR1","doi-asserted-by":"crossref","first-page":"e0144337","DOI":"10.1371\/journal.pone.0144337","volume":"10","author":"TB Ali","year":"2015","unstructured":"Ali TB, Schleret TR, Reilly BM, Chen WY, Abagyan R (2015) Adverse effects of cholinesterase inhibitors in dementia, according to the pharmacovigilance databases of the United-States and Canada. PLoS One 10:e0144337","journal-title":"PLoS One"},{"key":"752_CR2","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/jn\/136.8.2213","volume":"136","author":"I Andreadou","year":"2006","unstructured":"Andreadou I et al (2006) The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits. J Nutr 136:2213\u20132219","journal-title":"J Nutr"},{"key":"752_CR3","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1021\/acs.biochem.5b00459","volume":"54","author":"FA Aprile","year":"2015","unstructured":"Aprile FA, Sormanni P, Vendruscolo M (2015) A rational design strategy for the selective activity enhancement of a molecular chaperone toward a target substrate. Biochemistry 54:5103\u20135112","journal-title":"Biochemistry"},{"key":"752_CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12551-017-0317-z","volume":"9","author":"CL Avila","year":"2017","unstructured":"Avila CL et al (2017) Lessons learned from protein aggregation: toward technological and biomedical applications. Biophys Rev 9:501\u2013515","journal-title":"Biophys Rev"},{"key":"752_CR5","doi-asserted-by":"crossref","first-page":"14578","DOI":"10.1021\/jp509213f","volume":"118","author":"A Baumketner","year":"2014","unstructured":"Baumketner A (2014) Electric field as a disaggregating agent for amyloid fibrils. J Phys Chem B 118:14578\u201314589","journal-title":"J Phys Chem B"},{"key":"752_CR6","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1017\/S104161021800011X","volume":"30","author":"S Behrens","year":"2018","unstructured":"Behrens S et al (2018) Use of FDA approved medications for Alzheimer\u2019s disease in mild dementia is associated with reduced informal costs of care. Int Psychogeriatr 30:1499\u20131507","journal-title":"Int Psychogeriatr"},{"key":"752_CR7","doi-asserted-by":"crossref","unstructured":"Bekard I, Dunstan DE (2014) Electric field induced changes in protein conformation Soft Matter 10:431\u2013437","DOI":"10.1039\/C3SM52653D"},{"key":"752_CR8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1517\/13543776.2013.772983","volume":"23","author":"F Belluti","year":"2013","unstructured":"Belluti F, Rampa A, Gobbi S, Bisi A (2013) Small-molecule inhibitors\/modulators of amyloid-\u03b2 peptide aggregation and toxicity for the treatment of Alzheimer\u2019s disease: a patent review (2010\u20132012). Expert Opin Ther Patents 23:581\u2013596","journal-title":"Expert Opin Ther Patents"},{"key":"752_CR9","first-page":"xxxii","volume-title":"John L TYMOCZKO a Lubert STRYER. Biochemistry","author":"JM Berg","year":"2002","unstructured":"Berg JM (2002) John L TYMOCZKO a Lubert STRYER. Biochemistry, vol c2012. WH Freeman and Company, New York, p xxxii"},{"key":"752_CR10","doi-asserted-by":"crossref","first-page":"e35559","DOI":"10.1371\/journal.pone.0035559","volume":"7","author":"M Biasutti","year":"2012","unstructured":"Biasutti M, Dufour N, Ferroud C, Dab W, Temime L (2012) Cost-effectiveness of magnetic resonance imaging with a new contrast agent for the early diagnosis of Alzheimer\u2019s disease. PLoS One 7:e35559","journal-title":"PLoS One"},{"key":"752_CR11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm.2221","volume":"16","author":"K Blennow","year":"2010","unstructured":"Blennow K (2010) Biomarkers in Alzheimer\u2019s disease drug development. Nat Med 16:1218","journal-title":"Nat Med"},{"key":"752_CR12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/jnnp.2007.141853","volume":"80","author":"PS Boggio","year":"2009","unstructured":"Boggio PS, Khoury LP, Martins DC, Martins OE, De Macedo E, Fregni F (2009) Temporal cortex direct current stimulation enhances performance on a visual recognition memory task in Alzheimer disease. J Neurol Neurosurg Psychiatry 80:444\u2013447","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"752_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2011-110977","volume":"28","author":"B Bohrmann","year":"2012","unstructured":"Bohrmann B et al (2012) Gantenerumab: a novel human anti-A\u03b2 antibody demonstrates sustained cerebral amyloid-\u03b2 binding and elicits cell-mediated removal of human amyloid-\u03b2. J Alzheimers Dis 28:49\u201369","journal-title":"J Alzheimers Dis"},{"key":"752_CR14","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3390\/ijms19051443","volume":"19","author":"MN Bongiovanni","year":"2018","unstructured":"Bongiovanni MN, Aprile FA, Sormanni P, Vendruscolo M (2018) A rationally designed Hsp70 variant rescues the aggregation-associated toxicity of human IAPP in cultured pancreatic islet \u03b2-cells. Int J Mol Sci 19:1443","journal-title":"Int J Mol Sci"},{"key":"752_CR15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00005072-199005000-00003","volume":"49","author":"H Braak","year":"1990","unstructured":"Braak H, Braak E (1990) Alzheimer\u2019s disease: striatal amyloid deposits and neurofibrillary changes. J Neuropathol Exp Neurol 49:215\u2013224","journal-title":"J Neuropathol Exp Neurol"},{"key":"752_CR16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/WCO.0000000000000669","volume":"32","author":"SS Buss","year":"2019","unstructured":"Buss SS, Fried PJ, Pascual-Leone A (2019) Therapeutic noninvasive brain stimulation in Alzheimer\u2019s disease and related dementias. Curr Opin Neurol 32:292\u2013304","journal-title":"Curr Opin Neurol"},{"key":"752_CR17","doi-asserted-by":"crossref","unstructured":"Carpentier A et al (2016) Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci Transl Med 8:343re342\u2013343re342","DOI":"10.1126\/scitranslmed.aaf6086"},{"key":"752_CR18","doi-asserted-by":"publisher","unstructured":"Carvajal FJ, Mattison HA, Cerpa W (2016) Role of NMDA receptor-mediated glutamatergic signaling in chronic and acute neuropathologies. Neural Plast. https:\/\/doi.org\/10.1155\/2016\/2701526","DOI":"10.1155\/2016\/2701526"},{"key":"752_CR19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1389201053642321","volume":"6","author":"C Chakraborty","year":"2005","unstructured":"Chakraborty C, Nandi S, Jana S (2005) Prion disease: a deadly disease for protein misfolding. Curr Pharm Biotechnol 6:167\u2013177","journal-title":"Curr Pharm Biotechnol"},{"key":"752_CR20","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"G-F Chen","year":"2017","unstructured":"Chen G-F, Xu T-H, Yan Y, Zhou Y-R, Jiang Y, Melcher K, Xu HE (2017) Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin 38:1205","journal-title":"Acta Pharmacol Sin"},{"key":"752_CR21","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1016\/j.bbagen.2013.06.029","volume":"1830","author":"B Cheng","year":"2013","unstructured":"Cheng B, Gong H, Xiao H, Petersen RB, Zheng L, Huang K (2013) Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases. Biochim Biophys Acta Gen Subj 1830:4860\u20134871","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"752_CR22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2174\/1567205011666141107150331","volume":"11","author":"K Cisek","year":"2014","unstructured":"Cisek K, Cooper GL, Huseby CJ, Kuret J (2014) Structure and mechanism of action of tau aggregation inhibitors. Curr Alzheimer Res 11:918\u2013927","journal-title":"Curr Alzheimer Res"},{"key":"752_CR23","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1038\/srep09649","volume":"5","author":"GA Crespi","year":"2015","unstructured":"Crespi GA, Hermans SJ, Parker MW, Miles LA (2015) Molecular basis for mid-region amyloid-\u03b2 capture by leading Alzheimer\u2019s disease immunotherapies. Sci Rep 5:9649","journal-title":"Sci Rep"},{"key":"752_CR24","first-page":"210","volume":"119","author":"V Cubinkova","year":"2018","unstructured":"Cubinkova V, Valachova B, Uhrinova I, Brezovakova V, Smolek T, Jadhav S, Zilka N (2018) Alternative hypotheses related to Alzheimer\u2019s disease. Bratisl Lek Listy 119:210\u2013216","journal-title":"Bratisl Lek Listy"},{"key":"752_CR25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3233\/JAD-2010-100894","volume":"23","author":"L De Taboada","year":"2011","unstructured":"De Taboada L et al (2011) Transcranial laser therapy attenuates amyloid-\u03b2 peptide neuropathology in amyloid-\u03b2 protein precursor transgenic mice. J Alzheimers Dis 23:521\u2013535","journal-title":"J Alzheimers Dis"},{"key":"752_CR26","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2147\/DDDT.S86463","volume":"10","author":"WJ Deardorff","year":"2016","unstructured":"Deardorff WJ, Grossberg GT (2016) A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer\u2019s disease. Drug Des Dev Ther 10:3267","journal-title":"Drug Des Dev Ther"},{"key":"752_CR27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0301-4622(82)80028-8","volume":"15","author":"S Diekmann","year":"1982","unstructured":"Diekmann S, Hillen W, Jung M, Wells RD, P\u00f6rschke D (1982) Electric properties and structure of DNA restriction fragments from measurements of the electric dichroism. Biophys Chem 15:157\u2013167","journal-title":"Biophys Chem"},{"key":"752_CR28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0968-0004(99)01445-0","volume":"24","author":"CM Dobson","year":"1999","unstructured":"Dobson CM (1999) Protein misfolding, evolution and disease. Trends Biochem Sci 24:329\u2013332","journal-title":"Trends Biochem Sci"},{"key":"752_CR29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1098\/rstb.2000.0758","volume":"356","author":"CM Dobson","year":"2001","unstructured":"Dobson CM (2001) The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci 356:133\u2013145","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"752_CR30","doi-asserted-by":"publisher","unstructured":"Dobson CM (2004) Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol. Eds Ellis J, Klein WH, Mu X (Associated Press, New York) 15:3\u201316. https:\/\/doi.org\/10.1016\/j.semcdb.2003.12.008","DOI":"10.1016\/j.semcdb.2003.12.008"},{"key":"752_CR31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.sbi.2014.12.004","volume":"30","author":"AJ Doig","year":"2015","unstructured":"Doig AJ, Derreumaux P (2015) Inhibition of protein aggregation and amyloid formation by small molecules. Curr Opin Struct Biol 30:50\u201356","journal-title":"Curr Opin Struct Biol"},{"key":"752_CR32","doi-asserted-by":"publisher","unstructured":"Dolan PJ, Zago W (2018) Passive Immunotherapy in Alzheimer\u2019s Disease. In: Dorszewska J, Kozubski W (eds) Alzheimer\u2019s Disease \u2010 The 21st Century Challenge. London: IntechOpen, London. https:\/\/doi.org\/10.5772\/intechopen.76299","DOI":"10.5772\/intechopen.76299"},{"key":"752_CR33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000095264","volume":"3","author":"F Fahrenholz","year":"2006","unstructured":"Fahrenholz F, Postina R (2006) \u03b1-Secretase activation\u2014an approach to Alzheimer\u2019s disease therapy. Neurodegener Dis 3:255\u2013261","journal-title":"Neurodegener Dis"},{"key":"752_CR34","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archneur.65.8.1031","volume":"65","author":"AS Fleisher","year":"2008","unstructured":"Fleisher AS et al (2008) Phase 2 safety trial targeting amyloid \u03b2 production with a \u03b3-secretase inhibitor in Alzheimer disease. Arch Neurol 65:1031\u20131038","journal-title":"Arch Neurol"},{"key":"752_CR35","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1074\/jbc.M211485200","volume":"278","author":"R Fluhrer","year":"2003","unstructured":"Fluhrer R et al (2003) Identification of a \u03b2-secretase activity, which truncates amyloid \u03b2-peptide after its presenilin-dependent generation. J Biol Chem 278:5531\u20135538","journal-title":"J Biol Chem"},{"key":"752_CR36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/ncpneuro0530","volume":"3","author":"F Fregni","year":"2007","unstructured":"Fregni F, Pascual-Leone A (2007) Technology insight: noninvasive brain stimulation in neurology\u2014perspectives on the therapeutic potential of rTMS and tDCS. Nat Rev Neurol 3:383\u2013393. https:\/\/doi.org\/10.1038\/ncpneuro0530","journal-title":"Nat Rev Neurol"},{"key":"752_CR37","first-page":"611","volume":"46","author":"C Freitas","year":"2011","unstructured":"Freitas C, Mondrag\u00f3n-Llorca H, Pascual-Leone A (2011) Noninvasive brain stimulation in Alzheimer\u2019s disease: systematic review and perspectives for the future. Exp Gerontol 46:611\u2013627","journal-title":"Exp Gerontol"},{"key":"752_CR38","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1002\/chem.201504950","volume":"22","author":"M Frenkel-Pinter","year":"2016","unstructured":"Frenkel-Pinter M, Richman M, Belostozky A, Abu-Mokh A, Gazit E, Rahimipour S, Segal D (2016) Selective inhibition of aggregation and toxicity of a tau-derived peptide using its glycosylated analogues. Chem Eur J 22:5945\u20135952","journal-title":"Chem Eur J"},{"key":"752_CR39","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","volume":"97","author":"P Friedhoff","year":"2000","unstructured":"Friedhoff P, Biernat J, Heberle J, Mandelkow E, Mandelkow E (2000) Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306) VQIVYK (311)) forming beta structure. Proc Natl Acad Sci U S A 97:5129\u20135134","journal-title":"Proc Natl Acad Sci U S A"},{"key":"752_CR40","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1021\/bi500910b","volume":"53","author":"Z Fu","year":"2014","unstructured":"Fu Z, Aucoin D, Ahmed M, Ziliox M, Van Nostrand WE, Smith SO (2014) Capping of A\u03b242 oligomers by small molecule inhibitors. Biochemistry 53:7893\u20137903","journal-title":"Biochemistry"},{"key":"752_CR41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharep.2015.07.006","volume":"68","author":"J Gody\u0144","year":"2016","unstructured":"Gody\u0144 J, Jo\u0144czyk J, Panek D, Malawska B (2016) Therapeutic strategies for Alzheimer\u2019s disease in clinical trials. Pharmacol Rep 68:127\u2013138","journal-title":"Pharmacol Rep"},{"key":"752_CR42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2174\/1567205013666160930113907","volume":"14","author":"I Gonsalvez","year":"2017","unstructured":"Gonsalvez I, Baror R, Fried P, Santarnecchi E, Pascual-Leone A (2017) Therapeutic noninvasive brain stimulation in Alzheimer\u2019s disease. Curr Alzheimer Res 14:362\u2013376","journal-title":"Curr Alzheimer Res"},{"key":"752_CR43","first-page":"55","volume":"19","author":"D Goyal","year":"2017","unstructured":"Goyal D, Shuaib S, Mann S, Goyal B (2017) Rationally designed peptides and peptidomimetics as inhibitors of amyloid-\u03b2 (A\u03b2) aggregation: potential therapeutics of Alzheimer\u2019s disease ACS combinatorial. Science 19:55\u201380","journal-title":"Science"},{"key":"752_CR44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuropharm.2010.07.013","volume":"59","author":"I Granic","year":"2010","unstructured":"Granic I et al (2010) Calpain inhibition prevents amyloid-\u03b2-induced neurodegeneration and associated behavioral dysfunction in rats. Neuropharmacology 59:334\u2013342","journal-title":"Neuropharmacology"},{"key":"752_CR45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.genom.7.080505.115737","volume":"7","author":"N Gregersen","year":"2006","unstructured":"Gregersen N, Bross P, Vang S, Christensen JH (2006) Protein misfolding and human disease. Annu Rev Genomics Hum Genet 7:103\u2013124","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"752_CR46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/nan.12192","volume":"41","author":"F Gr\u00fcninger","year":"2015","unstructured":"Gr\u00fcninger F (2015) Invited review: drug development for tauopathies. Neuropathol Appl Neurobiol 41:81\u201396","journal-title":"Neuropathol Appl Neurobiol"},{"key":"752_CR47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat Rev Mol Cell Biol 8:101","journal-title":"Nat Rev Mol Cell Biol"},{"key":"752_CR48","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0361-9230(03)00087-X","volume":"61","author":"H Hampel","year":"2003","unstructured":"Hampel H, Goernitz A, Buerger K (2003) Advances in the development of biomarkers for Alzheimer\u2019s disease: from CSF total tau and A\u03b21\u201342 proteins to phosphorylated tau protein. Brain Res Bull 61:243\u2013253","journal-title":"Brain Res Bull"},{"key":"752_CR49","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3115","volume":"9","author":"H Hampel","year":"2010","unstructured":"Hampel H et al (2010) Biomarkers for Alzheimer\u2019s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov 9:560","journal-title":"Nat Rev Drug Discov"},{"key":"752_CR50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fpsyt.2012.00048","volume":"3","author":"N Hansen","year":"2012","unstructured":"Hansen N (2012) Action mechanisms of transcranial direct current stimulation in Alzheimer\u2019s disease and memory loss. Front Psychiatry 3:48","journal-title":"Front Psychiatry"},{"key":"752_CR51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256:184\u2013186","journal-title":"Science"},{"key":"752_CR52","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356","journal-title":"Science"},{"key":"752_CR53","doi-asserted-by":"crossref","first-page":"e0164278","DOI":"10.1371\/journal.pone.0164278","volume":"11","author":"RJ Hatch","year":"2016","unstructured":"Hatch RJ, Leinenga G, G\u00f6tz J (2016) Scanning ultrasound (SUS) causes no changes to neuronal excitability and prevents age-related reductions in hippocampal CA1 dendritic structure in wild-type mice. PLoS One 11:e0164278","journal-title":"PLoS One"},{"key":"752_CR54","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41593-018-0177-2","volume":"21","author":"CM Henstridge","year":"2018","unstructured":"Henstridge CM, Spires-Jones TL (2018) Modeling Alzheimer\u2019s disease brains in vitro. Nat Neurosci 21:899","journal-title":"Nat Neurosci"},{"key":"752_CR55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","volume":"378","author":"LS Honig","year":"2018","unstructured":"Honig LS et al (2018) Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease. N Engl J Med 378:321\u2013330","journal-title":"N Engl J Med"},{"key":"752_CR56","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1002\/ange.201400735","volume":"126","author":"F Huang","year":"2014","unstructured":"Huang F et al (2014) Maintenance of amyloid \u03b2 peptide homeostasis by artificial chaperones based on mixed-sshell polymeric micelles. Angew Chem 126:9131\u20139136","journal-title":"Angew Chem"},{"key":"752_CR57","doi-asserted-by":"crossref","first-page":"25109","DOI":"10.1074\/jbc.M003554200","volume":"275","author":"E Hughes","year":"2000","unstructured":"Hughes E, Burke RM, Doig AJ (2000) Inhibition of toxicity in the \u03b2-amyloid peptide fragment \u03b2-(25\u201335) using N-methylated derivatives: a general strategy to prevent amyloid formation. J Biol Chem 275:25109\u201325115","journal-title":"J Biol Chem"},{"key":"752_CR58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","volume":"6","author":"JW Johnson","year":"2006","unstructured":"Johnson JW, Kotermanski SE (2006) Mechanism of action of memantine. Curr Opin Pharmacol 6:61\u201367","journal-title":"Curr Opin Pharmacol"},{"key":"752_CR59","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fnins.2015.00500","volume":"9","author":"DM Johnstone","year":"2016","unstructured":"Johnstone DM, Moro C, Stone J, Benabid A-L, Mitrofanis J (2016) Turning on lights to stop neurodegeneration: the potential of near infrared light therapy in Alzheimer\u2019s and Parkinson\u2019s disease. Front Neurosci 9:500","journal-title":"Front Neurosci"},{"key":"752_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12551-019-00606-2","volume":"11","author":"S Jokar","year":"2019","unstructured":"Jokar S, Khazaei S, Behnammanesh H, Shamloo A, Erfani M, Beiki D, Bavi O (2019) Recent advances in the design and applications of amyloid-\u03b2 peptide aggregation inhibitors for Alzheimer\u2019s disease therapy. Biophys Rev 11:1\u201325. https:\/\/doi.org\/10.1007\/s12551-019-00606-2","journal-title":"Biophys Rev"},{"key":"752_CR61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2018.00025","volume":"12","author":"F Kametani","year":"2018","unstructured":"Kametani F, Hasegawa M (2018) Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease. Front Neurosci 12:25","journal-title":"Front Neurosci"},{"key":"752_CR62","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bpc.2014.08.009","volume":"196","author":"CM Kelly","year":"2015","unstructured":"Kelly CM, Northey T, Ryan K, Brooks BR, Kholkin AL, Rodriguez BJ, Buchete N-V (2015) Conformational dynamics and aggregation behavior of piezoelectric diphenylalanine peptides in an external electric field. Biophys Chem 196:16\u201324","journal-title":"Biophys Chem"},{"key":"752_CR63","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/d41586-018-05722-9","volume":"559","author":"A King","year":"2018","unstructured":"King A (2018) The search for better animal models of Alzheimer\u2019s disease. Nature 559:S13\u2013S15","journal-title":"Nature"},{"key":"752_CR64","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","volume":"15","author":"TP Knowles","year":"2014","unstructured":"Knowles TP, Vendruscolo M, Dobson CM (2014) The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol 15:384","journal-title":"Nat Rev Mol Cell Biol"},{"key":"752_CR65","doi-asserted-by":"crossref","first-page":"9906","DOI":"10.1021\/bi060837s","volume":"45","author":"N Kokkoni","year":"2006","unstructured":"Kokkoni N, Stott K, Amijee H, Mason JM, Doig AJ (2006) N-methylated peptide inhibitors of \u03b2-amyloid aggregation and toxicity. Optimization of the inhibitor structure. Biochemistry 45:9906\u20139918","journal-title":"Biochemistry"},{"key":"752_CR66","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.7150\/thno.5576","volume":"2","author":"EE Konofagou","year":"2012","unstructured":"Konofagou EE (2012) Optimization of the ultrasound-induced blood-brain barrier opening. Theranostics 2:1223","journal-title":"Theranostics"},{"key":"752_CR67","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","volume":"83","author":"KS KoSIK","year":"1986","unstructured":"KoSIK KS, Joachim CL, Selkoe DJ (1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci 83:4044\u20134048","journal-title":"Proc Natl Acad Sci"},{"key":"752_CR68","doi-asserted-by":"crossref","first-page":"12288","DOI":"10.1021\/jo4020722","volume":"78","author":"S Kotha","year":"2013","unstructured":"Kotha S, Goyal D, Chavan AS (2013) Diversity-oriented approaches to unusual \u03b1-amino acids and peptides: step economy, atom economy, redox economy, and beyond. J Org Chem 78:12288\u201312313","journal-title":"J Org Chem"},{"key":"752_CR69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1134\/S0026893315020065","volume":"49","author":"AA Kulikova","year":"2015","unstructured":"Kulikova AA, Makarov AA, Kozin S (2015) Roles of zinc ions and structural polymorphism of \u03b2-amyloid in the development of Alzheimer\u2019s disease. Mol Biol 49:217\u2013230","journal-title":"Mol Biol"},{"key":"752_CR70","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1074\/jbc.M110.173856","volume":"286","author":"ARA Ladiwala","year":"2011","unstructured":"Ladiwala ARA, Dordick JS, Tessier PM (2011) Aromatic small molecules remodel toxic soluble oligomers of amyloid \u03b2 through three independent pathways. J Biol Chem 286:3209\u20133218","journal-title":"J Biol Chem"},{"key":"752_CR71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biomaterials.2014.10.058","volume":"38","author":"JS Lee","year":"2015","unstructured":"Lee JS, Lee BI, Park CB (2015) Photo-induced inhibition of Alzheimer\u2019s \u03b2-amyloid aggregation in vitro by rose bengal. Biomaterials 38:43\u201349","journal-title":"Biomaterials"},{"key":"752_CR72","doi-asserted-by":"crossref","first-page":"278ra233-278ra2","DOI":"10.1126\/scitranslmed.aaa2512","volume":"7","author":"G Leinenga","year":"2015","unstructured":"Leinenga G, G\u00f6tz J (2015) Scanning ultrasound removes amyloid-\u03b2 and restores memory in an Alzheimer\u2019s disease mouse model. Sci Transl Med 7:278ra233-278ra233","journal-title":"Sci Transl Med"},{"key":"752_CR73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1471-4159.2010.07081.x","volume":"116","author":"SF Lichtenthaler","year":"2011","unstructured":"Lichtenthaler SF (2011) Alpha-secretase in Alzheimer\u2019s disease: molecular identity, regulation and therapeutic potential. J Neurochem 116:10\u201321","journal-title":"J Neurochem"},{"key":"752_CR74","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.4103\/0366-6999.247217","volume":"131","author":"Y-C Lin","year":"2018","unstructured":"Lin Y-C, Wang Y-P (2018) Status of noninvasive brain stimulation in the therapy of Alzheimer\u2019s disease. Chin Med J 131:2899","journal-title":"Chin Med J"},{"key":"752_CR75","doi-asserted-by":"crossref","first-page":"045105","DOI":"10.1063\/1.5018459","volume":"148","author":"Y Lu","year":"2018","unstructured":"Lu Y, Shi X-F, Salsbury FR Jr, Derreumaux P (2018) Influence of electric field on the amyloid-\u03b2 (29-42) peptides embedded in a membrane bilayer. J Chem Phys 148:045105","journal-title":"J Chem Phys"},{"key":"752_CR76","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1021\/ct1001335","volume":"6","author":"F Lugli","year":"2010","unstructured":"Lugli F, Toschi F, Biscarini F, Zerbetto F (2010) Electric field effects on short fibrils of A\u03b2 amyloid peptides. J Chem Theory Comput 6:3516\u20133526","journal-title":"J Chem Theory Comput"},{"key":"752_CR77","doi-asserted-by":"crossref","first-page":"1805945","DOI":"10.1002\/adma.201805945","volume":"32","author":"FH Ma","year":"2020","unstructured":"Ma FH, Li C, Liu Y, Shi L (2020) Mimicking molecular chaperones to regulate protein folding. Adv Mater 32:1805945","journal-title":"Adv Mater"},{"key":"752_CR78","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/bip.1980.360191103","volume":"19","author":"P Manavalan","year":"1980","unstructured":"Manavalan P, Momany FA (1980) Conformational energy studies on N-methylated analogs of thyrotropin releasing hormone, enkephalin, and luteinizing hormone-releasing hormone. Biopolymers 19:1943\u20131973","journal-title":"Biopolymers"},{"key":"752_CR79","first-page":"a006247","volume":"2","author":"E-M Mandelkow","year":"2012","unstructured":"Mandelkow E-M, Mandelkow E (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2:a006247","journal-title":"Cold Spring Harb Perspect Med"},{"key":"752_CR80","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brs.2012.03.004","volume":"5","author":"R Manenti","year":"2012","unstructured":"Manenti R, Cotelli M, Robertson IH, Miniussi C (2012) Transcranial brain stimulation studies of episodic memory in young adults, elderly adults and individuals with memory dysfunction: a review. Brain Stimul 5:103\u2013109","journal-title":"Brain Stimul"},{"key":"752_CR81","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S1388-2457(03)00046-4","volume":"114","author":"B Martis","year":"2003","unstructured":"Martis B et al (2003) Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clin Neurophysiol 114:1125\u20131132","journal-title":"Clin Neurophysiol"},{"key":"752_CR82","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ncpneuro0139","volume":"2","author":"K Matthews","year":"2006","unstructured":"Matthews K (2006) Tau protein abnormalities correlate with the severity of dementia in Alzheimer\u2019s disease. Nat Rev Neurol 2:178","journal-title":"Nat Rev Neurol"},{"key":"752_CR83","doi-asserted-by":"crossref","first-page":"11242","DOI":"10.1074\/jbc.M113.537472","volume":"289","author":"V Minicozzi","year":"2014","unstructured":"Minicozzi V et al (2014) Computational and experimental studies on \u03b2-sheet breakers targeting A\u03b21\u201340 fibrils. J Biol Chem 289:11242\u201311252","journal-title":"J Biol Chem"},{"key":"752_CR84","first-page":"2","volume":"1","author":"B Mohanty","year":"2017","unstructured":"Mohanty B (2017) A review on current therapies and challenges in Alzheimer\u2019s disease and role of Indian spices in its treatment as a futuristic approach. Neurol Clin Ther J 1:2","journal-title":"Neurol Clin Ther J"},{"key":"752_CR85","doi-asserted-by":"publisher","unstructured":"Nitsche MA, Liebetanz D, Antal A, Lang N, Tergau F, Paulus W (2003) Modulation of cortical excitability by weak direct current stimulation\u2013technical, safety and functional aspects. In: Suppl Clin Neurophysiol 56:255\u2013276. https:\/\/doi.org\/10.1016\/S1567-424X(09)70230-2","DOI":"10.1016\/S1567-424X(09)70230-2"},{"key":"752_CR86","doi-asserted-by":"crossref","first-page":"12254","DOI":"10.1021\/bi801767k","volume":"47","author":"B O\u2019Nuallain","year":"2008","unstructured":"O\u2019Nuallain B et al (2008) Human plasma contains cross-reactive A\u03b2 conformer-specific IgG antibodies. Biochemistry 47:12254\u201312256","journal-title":"Biochemistry"},{"key":"752_CR87","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bpj.2010.04.040","volume":"99","author":"P Ojeda-May","year":"2010","unstructured":"Ojeda-May P, Garcia ME (2010) Electric field-driven disruption of a native \u03b2-sheet protein conformation and generation of a helix-structure. Biophys J 99:595\u2013599","journal-title":"Biophys J"},{"key":"752_CR88","doi-asserted-by":"crossref","first-page":"305401","DOI":"10.1088\/0022-3727\/47\/30\/305401","volume":"47","author":"NK Pandey","year":"2014","unstructured":"Pandey NK, Mitra S, Chakraborty M, Ghosh S, Sen S, Dasgupta S, DasGupta S (2014) Disruption of human serum albumin fibrils by a static electric field. J Phys D Appl Phys 47:305401","journal-title":"J Phys D Appl Phys"},{"key":"752_CR89","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1038\/s41598-017-02609-z","volume":"7","author":"G Pandey","year":"2017","unstructured":"Pandey G et al (2017) Modulation of peptide based nano-assemblies with electric and magnetic fields. Sci Rep 7:2726. https:\/\/doi.org\/10.1038\/s41598-017-02609-z","journal-title":"Sci Rep"},{"key":"752_CR90","doi-asserted-by":"crossref","unstructured":"Pandey G, Morla S, Nemade HB, Kumar S, Ramakrishnan V (2019) Modulation of aggregation with an electric field; scientific roadmap for a potential non-invasive therapy against tauopathies. RSC Adv 9:4744\u20134750","DOI":"10.1039\/C8RA09993F"},{"key":"752_CR91","doi-asserted-by":"publisher","unstructured":"Pandey G, Morla S, Kumar S, Ramakrishnan V (2020) Modulation of tau protein aggregation using \u2018Trojan\u2019 sequences. Biochim Biophys Acta Gen Subj 129569. https:\/\/doi.org\/10.1016\/j.bbagen.2020.129569","DOI":"10.1016\/j.bbagen.2020.129569"},{"key":"752_CR92","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2217\/imt.11.170","volume":"4","author":"F Panza","year":"2012","unstructured":"Panza F et al (2012) Immunotherapy for Alzheimer\u2019s disease: from anti-\u03b2-amyloid to tau-based immunization strategies. Immunotherapy 4:213\u2013238","journal-title":"Immunotherapy"},{"key":"752_CR93","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2217\/imt-2016-0019","volume":"8","author":"F Panza","year":"2016","unstructured":"Panza F et al (2016) Tau-based therapeutics for Alzheimer\u2019s disease: active and passive immunotherapy. Immunotherapy 8:1119\u20131134","journal-title":"Immunotherapy"},{"key":"752_CR94","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1590\/S1980-57642009DN30300003","volume":"3","author":"VJR Paula","year":"2009","unstructured":"Paula VJR, Guimar\u00e3es FM, Diniz BS, Forlenza OV (2009) Neurobiological pathways to Alzheimer\u2019s disease: amyloid-beta, TAU protein or both? Dement Neuropsychol 3:188\u2013194","journal-title":"Dement Neuropsychol"},{"key":"752_CR95","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1096\/fj.01-0841fje","volume":"16","author":"B Permanne","year":"2002","unstructured":"Permanne B et al (2002) Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer\u2019s disease by treatment with a \u03b2-sheet breaker peptide. FASEB J 16:860\u2013862","journal-title":"FASEB J"},{"key":"752_CR96","doi-asserted-by":"publisher","unstructured":"P\u00f6rschke D (1987) Electric, optical and hydrodynamic parameters of lac repressor from measurements of the electric dichroism High permanent dipole moment associated with. Biophys Chem 28:137\u2013147. https:\/\/doi.org\/10.1016\/0301-4622(87)80083-2","DOI":"10.1016\/0301-4622(87)80083-2"},{"key":"752_CR97","volume-title":"World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence, Incidence","author":"M Prince","year":"2015","unstructured":"Prince M, Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina M(2015) World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends. Alzheimer's Disease International, London"},{"key":"752_CR98","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/alzrt232","volume":"6","author":"S Purushothuman","year":"2014","unstructured":"Purushothuman S, Johnstone DM, Nandasena C, Mitrofanis J, Stone J (2014) Photobiomodulation with near infrared light mitigates Alzheimer\u2019s disease-related pathology in cerebral cortex\u2014evidence from two transgenic mouse models. Alzheimers Res Ther 6:2","journal-title":"Alzheimers Res Ther"},{"key":"752_CR99","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2015.02.037","volume":"591","author":"S Purushothuman","year":"2015","unstructured":"Purushothuman S, Johnstone DM, Nandasena C, van Eersel J, Ittner LM, Mitrofanis J, Stone J (2015) Near infrared light mitigates cerebellar pathology in transgenic mouse models of dementia. Neurosci Lett 591:155\u2013159","journal-title":"Neurosci Lett"},{"key":"752_CR100","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/psc.2789","volume":"21","author":"T Qiu","year":"2015","unstructured":"Qiu T, Liu Q, Chen YX, Zhao YF, Li YM (2015) A\u03b242 and A\u03b240: similarities and differences. J Pept Sci 21:522\u2013529","journal-title":"J Pept Sci"},{"key":"752_CR101","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1039\/C6CC07803F","volume":"53","author":"A Qu","year":"2017","unstructured":"Qu A, Huang F, Li A, Yang H, Zhou H, Long J, Shi L (2017) The synergistic effect between KLVFF and self-assembly chaperones on both disaggregation of beta-amyloid fibrils and reducing consequent toxicity. Chem Commun 53:1289\u20131292","journal-title":"Chem Commun"},{"key":"752_CR102","doi-asserted-by":"crossref","first-page":"13434","DOI":"10.1039\/C5CC05264E","volume":"51","author":"K Rajasekhar","year":"2015","unstructured":"Rajasekhar K, Chakrabarti M, Govindaraju T (2015) Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer\u2019s disease. Chem Commun 51:13434\u201313450","journal-title":"Chem Commun"},{"key":"752_CR103","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1016\/j.bmc.2011.04.001","volume":"19","author":"T Richard","year":"2011","unstructured":"Richard T et al (2011) Protective effect of \u03b5-viniferin on \u03b2-amyloid peptide aggregation investigated by electrospray ionization mass spectrometry. Bioorg Med Chem 19:3152\u20133155","journal-title":"Bioorg Med Chem"},{"key":"752_CR104","doi-asserted-by":"crossref","first-page":"e2986","DOI":"10.1136\/bmj.e2986","volume":"344","author":"J Rodda","year":"2012","unstructured":"Rodda J, Carter J (2012) Cholinesterase inhibitors and memantine for symptomatic treatment of dementia. BMJ 344:e2986","journal-title":"BMJ"},{"key":"752_CR105","first-page":"2","volume-title":"Australian medicines handbook","author":"S Rossi","year":"2006","unstructured":"Rossi S (2006) Australian medicines handbook. Australian Medicines Handbook, Adelaide, pp 2\u20133"},{"key":"752_CR106","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1021\/acschemneuro.8b00490","volume":"10","author":"J Saikia","year":"2019","unstructured":"Saikia J et al (2019) Electric field disruption of amyloid aggregation: potential noninvasive therapy for Alzheimer\u2019s disease. ACS Chem Neurosci 10:2250\u20132262","journal-title":"ACS Chem Neurosci"},{"key":"752_CR107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1590\/S1807-59322011001300006","volume":"66","author":"EL Schaeffer","year":"2011","unstructured":"Schaeffer EL, Figueiro M, Gattaz WF (2011) Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics 66:45\u201354","journal-title":"Clinics"},{"key":"752_CR108","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.nbd.2012.03.005","volume":"46","author":"R Scherzer-Attali","year":"2012","unstructured":"Scherzer-Attali R et al (2012) Naphthoquinone-tyrptophan reduces neurotoxic A\u03b2* 56 levels and improves cognition in Alzheimer\u2019s disease animal model. Neurobiol Dis 46:663\u2013672","journal-title":"Neurobiol Dis"},{"key":"752_CR109","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nchem.2889","volume":"10","author":"P Seidler","year":"2018","unstructured":"Seidler P et al (2018) Structure-based inhibitors of tau aggregation. Nat Chem 10:170","journal-title":"Nat Chem"},{"key":"752_CR110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bpc.2017.04.004","volume":"226","author":"S Sen","year":"2017","unstructured":"Sen S, Chakraborty M, Goley S, Dasgupta S, Das Gupta S (2017) Fibrillar disruption by AC electric field induced oscillation: a case study with human serum albumin. Biophys Chem 226:23\u201333","journal-title":"Biophys Chem"},{"key":"752_CR111","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J et al (2016) The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537:50","journal-title":"Nature"},{"key":"752_CR112","first-page":"2944","volume":"8","author":"Z-Q Shao","year":"2015","unstructured":"Shao Z-Q (2015) Comparison of the efficacy of four cholinesterase inhibitors in combination with memantine for the treatment of Alzheimer\u2019s disease. Int J Clin Exp Med 8:2944","journal-title":"Int J Clin Exp Med"},{"key":"752_CR113","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000354491","volume":"13","author":"EM Sigurdsson","year":"2014","unstructured":"Sigurdsson EM (2014) Tau immunotherapy and imaging. Neurodegener Dis 13:103\u2013106","journal-title":"Neurodegener Dis"},{"key":"752_CR114","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsbi.2000.4221","volume":"130","author":"JD Sipe","year":"2000","unstructured":"Sipe JD, Cohen AS (2000) History of the amyloid fibril. J Struct Biol 130:88\u201398","journal-title":"J Struct Biol"},{"key":"752_CR115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/pho.2011.3073","volume":"30","author":"AP Sommer","year":"2012","unstructured":"Sommer AP et al (2012) 670 nm laser light and EGCG complementarily reduce amyloid-\u03b2 aggregates in human neuroblastoma cells: basis for treatment of Alzheimer\u2019s disease? Photomed Laser Surg 30:54\u201360","journal-title":"Photomed Laser Surg"},{"key":"752_CR116","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature25143","volume":"552","author":"V Sorrentino","year":"2017","unstructured":"Sorrentino V et al (2017) Enhancing mitochondrial proteostasis reduces amyloid-\u03b2 proteotoxicity. Nature 552:187","journal-title":"Nature"},{"key":"752_CR117","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12551-017-0271-9","volume":"9","author":"KL Stewart","year":"2017","unstructured":"Stewart KL, Radford SE (2017) Amyloid plaques beyond A\u03b2: a survey of the diverse modulators of amyloid aggregation. Biophys Rev 9:405\u2013419","journal-title":"Biophys Rev"},{"key":"752_CR118","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ageing\/afl027","volume":"35","author":"N Tabet","year":"2006","unstructured":"Tabet N (2006) Acetylcholinesterase inhibitors for Alzheimer\u2019s disease: anti-inflammatories in acetylcholine clothing! Age Ageing 35:336\u2013338","journal-title":"Age Ageing"},{"key":"752_CR119","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1021\/ar8000475","volume":"41","author":"T Takahashi","year":"2008","unstructured":"Takahashi T, Mihara H (2008) Peptide and protein mimetics inhibiting amyloid \u03b2-peptide aggregation. Acc Chem Res 41:1309\u20131318","journal-title":"Acc Chem Res"},{"key":"752_CR120","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1074\/jbc.271.15.8545","volume":"271","author":"LO Tjernberg","year":"1996","unstructured":"Tjernberg LO et al (1996) Arrest of-amyloid fibril formation by a pentapeptide ligand. J Biol Chem 271:8545\u20138548","journal-title":"J Biol Chem"},{"key":"752_CR121","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3233\/JAD-140741","volume":"43","author":"S Tucker","year":"2015","unstructured":"Tucker S et al (2015) The murine version of BAN2401 (mAb158) selectively reduces amyloid-\u03b2 protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice. J Alzheimers Dis 43:575\u2013588","journal-title":"J Alzheimers Dis"},{"key":"752_CR122","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1471-4914(02)02382-1","volume":"8","author":"F Ursini","year":"2002","unstructured":"Ursini F, Davies KJ, Maiorino M, Parasassi T, Sevanian A (2002) Atherosclerosis: another protein misfolding disease? Trends Mol Med 8:370\u2013374","journal-title":"Trends Mol Med"},{"key":"752_CR123","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0024-3205(97)01150-8","volume":"62","author":"F Visioli","year":"1998","unstructured":"Visioli F, Bellosta S, Galli C (1998) Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages. Life Sci 62:541\u2013546","journal-title":"Life Sci"},{"key":"752_CR124","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/med.1028","volume":"22","author":"F Visioli","year":"2002","unstructured":"Visioli F, Poli A, Gall C (2002) Antioxidant and other biological activities of phenols from olives and olive oil. Med Res Rev 22:65\u201375","journal-title":"Med Res Rev"},{"key":"752_CR125","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.neuroimage.2007.01.027","volume":"35","author":"T Wagner","year":"2007","unstructured":"Wagner T, Fregni F, Fecteau S, Grodzinsky A, Zahn M, Pascual-Leone A (2007) Transcranial direct current stimulation: a computer-based human model study. Neuroimage 35:1113\u20131124","journal-title":"Neuroimage"},{"key":"752_CR126","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-170560","volume":"61","author":"GK Wilcock","year":"2018","unstructured":"Wilcock GK et al (2018) Potential of low dose leuco-methylthioninium bis (hydromethanesulphonate)(LMTM) monotherapy for treatment of mild Alzheimer\u2019s disease: cohort analysis as modified primary outcome in a phase III clinical trial. J Alzheimers Dis 61:435\u2013457","journal-title":"J Alzheimers Dis"},{"key":"752_CR127","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.emboj.7601930","volume":"27","author":"KF Winklhofer","year":"2008","unstructured":"Winklhofer KF, Tatzelt J, Haass C (2008) The two faces of protein misfolding: gain-and loss-of-function in neurodegenerative diseases. EMBO J 27:336\u2013349","journal-title":"EMBO J"},{"key":"752_CR128","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bcp.2013.12.008","volume":"88","author":"CM Wischik","year":"2014","unstructured":"Wischik CM, Harrington CR, Storey JM (2014) Tau-aggregation inhibitor therapy for Alzheimer\u2019s disease. Biochem Pharmacol 88:529\u2013539","journal-title":"Biochem Pharmacol"},{"key":"752_CR129","doi-asserted-by":"crossref","first-page":"12108","DOI":"10.1021\/jp960076a","volume":"100","author":"D Xu","year":"1996","unstructured":"Xu D, Phillips JC, Schulten K (1996) Protein response to external electric fields: relaxation, hysteresis, and echo. J Phys Chem 100:12108\u201312121","journal-title":"J Phys Chem"},{"key":"752_CR130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756285612461679","volume":"6","author":"KG Yiannopoulou","year":"2013","unstructured":"Yiannopoulou KG, Papageorgiou SG (2013) Current and future treatments for Alzheimer\u2019s disease. Ther Adv Neurol Disord 6:19\u201333","journal-title":"Ther Adv Neurol Disord"},{"key":"752_CR131","doi-asserted-by":"crossref","first-page":"37147","DOI":"10.1021\/acsami.9b13708","volume":"11","author":"F Zhang","year":"2019","unstructured":"Zhang F, Hu C, Kong Q, Luo R, Wang Y (2019) Peptide-\/drug-directed self-assembly of hybrid polyurethane hydrogels for wound healing ACS. Appl Mater Interfaces 11:37147\u201337155","journal-title":"Appl Mater Interfaces"},{"key":"752_CR132","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/jp9081189","volume":"114","author":"W Zhao","year":"2009","unstructured":"Zhao W, Yang R (2009) Experimental study on conformational changes of lysozyme in solution induced by pulsed electric field and thermal stresses. J Phys Chem B 114:503\u2013510","journal-title":"J Phys Chem B"},{"key":"752_CR133","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2009-0925","volume":"16","author":"W Zhao","year":"2009","unstructured":"Zhao W, Wang J, Ho L, Ono K, Teplow DB, Pasinetti GM (2009) Identification of antihypertensive drugs which inhibit amyloid-\u03b2 protein oligomerization. J Alzheimers Dis 16:49\u201357","journal-title":"J Alzheimers Dis"},{"key":"752_CR134","doi-asserted-by":"crossref","first-page":"044123","DOI":"10.1063\/1.4928767","volume":"9","author":"Z Zheng","year":"2015","unstructured":"Zheng Z, Jing B, Sorci M, Belfort G, Zhu Y (2015) Accelerated insulin aggregation under alternating current electric fields: relevance to amyloid kinetics. Biomicrofluidics 9:044123","journal-title":"Biomicrofluidics"},{"key":"752_CR135","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/s41467-017-01799-4","volume":"8","author":"B Zhu","year":"2017","unstructured":"Zhu B et al (2017) ER-associated degradation regulates Alzheimer\u2019s amyloid pathology and memory function by modulating \u03b3-secretase activity. Nat Commun 8:1472","journal-title":"Nat Commun"}],"container-title":["Biophysical Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12551-020-00752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12551-020-00752-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12551-020-00752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T02:00:10Z","timestamp":1631671210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12551-020-00752-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":135,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1007\/s12551-020-00752-y","relation":{},"ISSN":["1867-2450","1867-2469"],"issn-type":[{"value":"1867-2450","type":"print"},{"value":"1867-2469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"assertion":[{"value":"12 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval for research involving human participants and\/or animals and informed consent"}}]}}